Scholars Central

Conference abstractPublished 20 May 2019

Mesoporous aluminosilicates-highly efficient catalysts of oligomerization of andalpha;- olefins

Authors: Angeline Tzeyung Shak, Shadab Md, Thiagarajan Madheswaran, Subrat Kumar Bhattamisra, Ammu K. Radhakrishnan

International Medical University, Malaysia King Abdulaziz University, Saudi Arabia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Rotigotine is a non-ergoline and selective dopaminergic (D2) receptor agonist which is effective in the treatment of Parkinsonâ??s disease. Despite the therapeutic potential, its long-term clinical practice has been hindered due to low oral bioavailability (1%) and extensive first-pass effect. The aim of this study was to develop and evaluate rotigotine-loaded chitosan nanoparticles (RNPs) for nose-to-brain delivery. RNPs were prepared by ionic gelation technique. The effect of chitosan, sodium tripolyphosphate and rotigotine concentration on particle size, polydispersity index (PDI), zeta potential and entrapment efficiency were optimized. Solid-state characterization studies include transmission electron microscopy, scanning electron microscopy, atomic force microscopy, fouriertransform infrared spectroscopy, differential scanning calorimetry and X-ray diffraction. The effect of RNPs on the integrity of mucosa was investigated by histopathological study of treated and untreated goat mucosa after 24 h of the drug permeation experiment. Cytotoxicity of RNPs was evaluated in human neuroblastoma SH-SY5Y cell using MTT assays. The optimized RNPs had a hydrodynamic particle size of 75.37 ± 3.37 nm, PDI of 0.368 ± 0.02, zeta potential of +25.53 ± 0.45 mV and entrapment efficiency of 96.08 ± 0.01%. There was no toxicity or structural damage to nasal mucosa by RNPs was observed in histopathological study. The cell viability was more than 90% after 24 h incubation with RNPs. RNPs showed neuroprotective effect against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity. Our results indicated that RNPs are a promising carrier for nose-to-brain delivery. In-vivo behavior of these nanoparticulate carriers should be further evaluated in animal models of Parkinsonâ??s disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Material Sciences & Engineering.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Material Sciences & Engineering
  • SubjectEngineering
  • SubjectMaterials Science
  • BylineArticles whose byline prints “Angeline Tzeyung Shak”
  • BylineArticles whose byline prints “Shadab Md”
  • BylineArticles whose byline prints “Thiagarajan Madheswaran”
  • BylineArticles whose byline prints “Subrat Kumar Bhattamisra”
  • BylineArticles whose byline prints “Ammu K. Radhakrishnan”